Contents
Academy · Publication Support · CONSORT
CONSORT Guidelines for Reporting Randomised Trials: A Guide to CONSORT 2025
CONSORT is the reporting guideline for randomised trials — not for observational studies or systematic reviews. The current version is CONSORT 2025, and it has 30 items.
CONSORT is the reporting guideline for randomised controlled trials. It does not tell you how to run a trial; it tells you what a published report has to contain so a reader can judge what was done. The current version is CONSORT 2025, and it has 30 items1.
CONSORT: Definition and Purpose
CONSORT (Consolidated Standards of Reporting Trials) was developed because trial reports often omitted the information needed to assess them. It is a reporting standard applied at the writing stage, and most major journals ask for a completed checklist at submission.
Its scope is randomised trials. Observational studies are reported against STROBE, systematic reviews against PRISMA, diagnostic accuracy studies against STARD and study protocols against SPIRIT. Guidance that lists systematic reviews or observational studies as requiring CONSORT reporting directs authors to the wrong checklist; the EQUATOR Network is the index to check against3.
CONSORT 2025: The Current Version
There have been three versions of the statement: CONSORT 2001, CONSORT 2010 and CONSORT 2025. CONSORT 2025 was published simultaneously across five journals:
Where CONSORT 2025 was published
| Journal | Citation | Identifier |
|---|---|---|
| BMJ | 2025;389:e081123 | doi:10.1136/bmj-2024-081123 |
| JAMA | 2025;333(22):1998–2005 | doi:10.1001/jama.2025.4347 |
| The Lancet | 2025, online | doi:10.1016/S0140-6736(25)00672-5 |
| Nature Medicine | 2025;31(6):1776–1783 | PMID 40229553 |
| PLoS Medicine | 2025;22(4):e1004587 | doi:10.1371/journal.pmed.1004587 |
An explanation and elaboration document was published alongside it, and its web appendix 1 maps CONSORT 2025 item by item against CONSORT 2010. It is the quickest way to identify the changes if you are familiar with the previous checklist2.
Citing the correct volume. The volume is 389. The official checklist PDF and the EQUATOR record both still print 388, which was the pre-pagination volume, so the wrong number is widely circulated. Cite 3891.
Changes from CONSORT 2010 to CONSORT 2025
The statement summarises its own changes: “We added seven new checklist items, revised three items, deleted one item, integrated several items from key CONSORT extensions.”1
The item count moved from 25 to 30. The seven new items are:
New in CONSORT 2025
| Item | What it requires |
|---|---|
| 4 | Data sharing |
| 5b | Authors’ conflicts of interest |
| 8 | Patient and public involvement |
| 12b | Eligibility of sites and of those delivering the intervention |
| 15 | How harms were assessed |
| 21b, 21c | Analysis populations, and how missing data were handled |
| 24 | Intervention delivery and concomitant care |
Three items were revised: 3 (access to the protocol and the statistical analysis plan), 10 (important changes after the trial commenced), 26 (numbers analysed, outcomes and estimation). One was deleted — generalisability, now incorporated under trial limitations (item 30).
CONSORT 2025 also absorbed items from four extensions: Harms, Outcomes, Non-pharmacological Treatment and TIDieR. If you previously used those extensions alongside CONSORT 2010, check what is now in the main checklist before applying both.
The most visible structural change is the new open science section, which brings registration, protocol and analysis plan availability, and data sharing to the front of the checklist.
The CONSORT 2025 Checklist by Section
30 items, 42 entries once lettered sub-items are counted:
CONSORT 2025 structure
| Section | Items | Count |
|---|---|---|
| Title and abstract | 1a, 1b | 1 |
| Open science | 2, 3, 4 | 3 |
| Funding and conflicts of interest | 5a, 5b | 1 |
| Introduction | 6, 7 | 2 |
| Methods | 8–21 | 14 |
| Results | 22–28 | 7 |
| Discussion | 29, 30 | 2 |
The Methods section accounts for almost half the checklist, reflecting where reporting most often falls short. The paper’s own Table 1 groups funding and conflicts of interest under open science, giving six sections, while the standalone checklist lists them separately, giving seven. The items are the same in both.
Download the checklist from the official SPIRIT–CONSORT site rather than from a third-party copy, because superseded versions circulate widely4.
The CONSORT Flow Diagram
The flow diagram is retained in CONSORT 2025. The statement describes it as “and a diagram for documenting the flow of participants through a trial (fig 1).”
Its stages are “(ie, enrolment, intervention allocation, follow-up, and data analysis)”
It is named in item 22, which asks for participant flow including the diagram. Item 22a requires “For each group, the numbers of participants who were randomly assigned, received intended intervention…”, and item 22b requires “For each group, losses and exclusions after randomisation, together with reasons”1.
In practice, the numbers in the diagram must reconcile: assessed for eligibility, excluded with reasons, randomised, received the intervention, lost to follow-up and analysed. Readers check these figures against the text, and discrepancies are among the most common reviewer queries.
A note on wording: the statement presents the diagram as part of the minimum reporting set and names it in item 22. It does not use the words “required” or “mandatory”, so the accurate description is that the diagram is retained and named in item 22, and journals treat it as expected.
CONSORT Extensions Versus Versions
An extension adapts CONSORT to a particular design, intervention type or outcome. An extension is not a version. Treating the 2017 non-pharmacological treatment extension as the successor to CONSORT 2010 is a common error. It is one of roughly two dozen extensions, and the successor to CONSORT 2010 is CONSORT 2025.
CONSORT extensions, with years
| Extension | Year |
|---|---|
| Abstracts | 2008 |
| Pragmatic trials | 2008 |
| Herbal interventions | 2006 |
| Cluster trials | 2012 |
| Non-inferiority and equivalence | 2012 |
| Patient-reported outcomes (CONSORT PRO) | 2013 |
| TIDieR | 2014 |
| N-of-1 trials (CENT) | 2015 |
| Pilot and feasibility trials | 2016 |
| Within-person randomised trials | 2017 |
| Non-pharmacological treatment interventions | 2017 |
| CONSORT-Equity | 2017 |
| Social and psychological interventions (CONSORT-SPI) | 2018 |
| Stepped wedge cluster trials | 2018 |
| Multi-arm parallel-group trials | 2019 |
| Crossover trials | 2019 |
| Adaptive designs (ACE) | 2020 |
| Artificial intelligence (CONSORT-AI) | 2020 |
| Routinely collected data (ROUTINE) | 2021 |
| Outcomes (CONSORT-Outcomes) | 2022 |
| Harms | 2022, published 2023 |
| Dose-finding (CONSORT-DEFINE) | 2023 |
| Factorial trials | 2023 |
| Surrogate endpoints | 2024 |
| Cluster randomised crossover (CRXO) | 2025 |
The EQUATOR Network is the index to search for one that fits your design3.
Use the main checklist plus any extension that applies to your design. A cluster randomised crossover trial of a non-pharmacological intervention uses more than one.
Using CONSORT in Practice
- Read the checklist before you write, not after. Several items, including patient and public involvement, how harms were assessed, and the eligibility of sites and intervention providers, describe activities that must have taken place during the trial, not only content to be written.
- Complete the checklist with page numbers. Journals ask for it, and completing it carefully identifies omissions while they can still be corrected.
- Use SPIRIT for the protocol and CONSORT for the report. The two guidelines are designed to align.
- Check EQUATOR for an applicable extension before submission.
- Make the flow diagram reconcile with the text before submission.
- Do not treat the checklist as a formatting exercise. Its purpose is to let readers understand what was done. A report that addresses every item but still obscures the analysis population has not complied.
Take-Home Message
CONSORT is the reporting guideline for randomised trials, not for observational studies or systematic reviews, which are reported against STROBE and PRISMA. The current version is CONSORT 2025, with 30 items in place of the 25 in CONSORT 2010: seven added, three revised, one deleted, and items integrated from the Harms, Outcomes, Non-pharmacological Treatment and TIDieR extensions. The flow diagram is retained and named in item 22. An extension is not a version: the 2017 non-pharmacological document is one of roughly two dozen extensions, not the successor to CONSORT 2010.
Applying CONSORT to Your Trial Report
How to Apply CONSORT to Your Own Work
- Check you are using CONSORT 2025, not 2010. Guidance published before April 2025 describes a superseded checklist.
- Cite BMJ 2025;389:e081123 — volume 389. The official checklist PDF and EQUATOR both still print 388.
- Read the open science section first, because registration, protocol availability and data sharing are decided before the trial begins, not at the writing stage.
- Check the seven new items against what you actually did, particularly patient and public involvement and harms assessment, which describe trial conduct as well as reporting.
- Complete the checklist with page numbers before submission, and reconcile the flow diagram against the text.
- Search EQUATOR for extensions that fit your design, and check whether the ones you used are now absorbed into the main checklist.
- Use SPIRIT for the protocol and CONSORT for the report, because the two guidelines are designed to align.
CONSORT FAQs
CONSORT 2025, published in April 2025 across the BMJ, JAMA, The Lancet, Nature Medicine and PLoS Medicine. It replaces CONSORT 2010. The only previous versions of the statement are CONSORT 2001 and CONSORT 2010.
Thirty, against twenty-five in CONSORT 2010 — 42 entries once lettered sub-items are counted. Seven items were added, three revised and one deleted, and items from the Harms, Outcomes, Non-pharmacological Treatment and TIDieR extensions were integrated into the main checklist.
No. CONSORT is for randomised trials. Systematic reviews are reported against PRISMA, observational studies against STROBE, diagnostic accuracy studies against STARD and protocols against SPIRIT. Using CONSORT for any of these means submitting the wrong checklist to the journal.
No. The 2017 document is the extension for non-pharmacological treatment interventions, one of roughly two dozen extensions. The successor to CONSORT 2010 is CONSORT 2025, and several items from the 2017 extension have now been integrated into the main checklist.
It is retained in CONSORT 2025 and named in item 22, which asks for participant flow including the diagram. It tracks enrolment, intervention allocation, follow-up and data analysis. In practice journals treat it as expected, and its numbers need to reconcile with the text.
From the official SPIRIT–CONSORT site, which the statement itself names. Superseded 2010 versions are widely available on third-party and publisher file-sharing sites, and an outdated version is easily downloaded by mistake.
References and Sources
- Hopewell S, Chan A-W, Collins GS, Hróbjartsson A, Moher D, Schulz KF, Tunn R, et al., Boutron I. CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ. 2025;389:e081123. doi:10.1136/bmj-2024-081123 read 15 October 2026. View on The BMJThe current version of record. The volume is 389: the official checklist PDF and the EQUATOR record both still print 388, which was the pre-pagination volume, so the incorrect number is widely circulated.
- Hopewell S, Chan A-W, Collins GS, et al. CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials. BMJ. 2025;389:e081124. doi:10.1136/bmj-2024-081124 read 15 October 2026. View on The BMJThe item-by-item rationale, including web appendix 1, which maps CONSORT 2025 against CONSORT 2010.
- EQUATOR Network. CONSORT reporting guideline record. read 15 October 2026. View on EQUATOR NetworkThe authoritative index of CONSORT and its extensions, and the place to check whether an extension applies to a given trial design.
- SPIRIT–CONSORT. Official site for the CONSORT and SPIRIT statements, checklists and flow diagram. read 15 October 2026. View on consort-spirit.orgThe statement and the checklist both name this as the official site. Navigate to the checklist from the site’s home page.
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts who carry out this work. Articles are revised when the underlying standards change, and each shows the date it was last checked.
How Pubrica Can Help
Pubrica’s publication support specialists prepare trial reports to CONSORT 2025, complete the submission checklist with page references, and build flow diagrams that reconcile with the reported analysis.